Clinical Trial Update: Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating the combination of irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma (liver cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Flavopiridol (alvocidib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED